Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
The growing body of evidence showing that GLP-1 medications reduce healthcare costs long-term is making more employers willing to add this benefit
Diabetologia 61 , 711721 (2018)
Stolakis et al., 2010
In a Phase 1 randomized, double-blind clinical study targeting obese participants (NCT04478708), AMG133 demonstrated acceptable safety, tolerability, and significant dose-dependent weight loss
The restoration of a normal redox equilibrium results in an increase in GSH/GSSG ratio
It was added because rodents developed thyroid C-cell tumors in animal studies, and that raised enough concern to justify a strong warning label
US$ 26.18
US$ 22.77
US$ 27.23
US$ 29.17
US$ 23.22
